3-甲氧基苯硫代甲酰胺 | 64559-06-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 3-甲氧基苯硫代甲酰胺
• 中文别名: 3-甲氧基硫代苯甲酰胺；3-甲氧基苯硫代酰胺
• 英文名称: 3-methoxythiobenzamide
• 英文别名: 3-methoxybenzothioamide；3-methoxybenzenecarbothioamide
• CAS: 64559-06-4
• 化学式: C₈H₉NOS
• mdl: MFCD04627361
• 分子量: 167.232
• InChiKey: LQSZSWBMLMGWPC-UHFFFAOYSA-N

物化性质

• 熔点：
  93-98°C
• 溶解度：
  DMF：30mg/mL； DMSO：30mg/mL； DMSO:PBS (pH 7.2) (1:10)：0.1 mg/ml；乙醇：3mg/mL

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  67.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险类别码：
  R36/37/38
• 海关编码：
  2930909090
• 安全说明：
  S26,S36/37/39
• WGK Germany：
  3
• 危险标志：
  GHS07
• 危险性描述：
  H317,H319
• 危险性防范说明：
  P280,P305 + P351 + P338
• 储存条件：
  室温

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
3-Methoxybenzenecarbothioamide
Product Name:
Synonyms: 3-Methoxythiobenzamide

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H317: May cause an allergic skin reaction
H319: Causes serious eye irritation
P280: Wear protective gloves/protective clothing/eye protection/face protection
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Methoxybenzenecarbothioamide
CAS number: 64559-06-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
This product should be handled only by, or under the close supervision of, those properly qualified
Handling:
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C8H9NOS
Molecular weight: 167.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-甲氧基苯硫代甲酰胺 在 1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下， 以 1,4-二氧六环 、 氯仿 、 乙腈 为溶剂， 反应 23.0h， 生成 3'-甲氧基-2-苯基-4-喹唑啉酮
  参考文献：
  名称：

  Mo（CO）6辅助Pd负载的氧化石墨烯催化的羰基化环化反应是合成4（3H）-喹唑啉酮的有效方法

  摘要：

  在本文中，基于钯在改性磁性氧化石墨烯纳米粒子上的固定化，引入了一种新型催化剂。该催化剂的特征在于几种方法，包括透射电子显微镜，扫描电子显微镜，X射线荧光，振动样品磁力计，傅立叶变换红外和动态光散射（DLS）分析。通过钯（Mo）（6）催化Pd催化N-（2-溴芳基）苯甲酰胺的羰基化环化反应，合成了4（3 H）-喹唑啉酮类催化剂。钼（CO）6用作一氧化碳源，用于在温和条件下进行反应。该催化剂显示出良好的可重复使用性，并且在10个回收周期后未观察到活性变化。

  DOI：

  10.1002/aoc.4769
• 作为产物：
  描述：

  3-methoxybenzaldehyde oxime 在 三氯硫磷 、 水 、 三乙胺 作用下， 反应 2.5h， 生成 3-甲氧基苯硫代甲酰胺
  参考文献：
  名称：

  硫代磷酰氯辅助将芳醛肟转化为硫代酰胺。

  摘要：

  使用硫代磷酰氯作为脱水剂和去硫剂，通过苯甲腈通过苯甲腈从苯甲醛肟（苯甲醛肟）中获得伯苯硫酰胺。 伯硫代酰胺-肟-硫代磷酰氯-腈

  DOI：

  10.1055/s-0031-1289994

文献信息

• Single-Step Microwave-Mediated Synthesis of Oxazoles and Thiazoles from 3-Oxetanone: A Synthetic and Computational Study
  作者：David Orr、Alexandra Tolfrey、Jonathan M. Percy、Joanna Frieman、Zoë A. Harrison、Matthew Campbell-Crawford、Vipulkumar K. Patel

  DOI：10.1002/chem.201301011

  日期：2013.7.15

  The direct microwave‐mediated condensation between 3‐oxetanone and primary amides and thioamides has delivered moderate to good yields of (hydroxymethyl)oxazoles and (hydroxymethyl)thiazoles. The reactions use a sustainable solvent and only require short reaction times. These are highly competitive methods for the construction of two classes of valuable heteroarenes, which bear a useful locus for further

  3-氧杂环丁酮与伯酰胺和硫代酰胺之间的直接微波介导缩合反应产生了中等到良好的（羟甲基）恶唑和（羟甲基）噻唑收率。反应使用可持续的溶剂，只需要很短的反应时间。这些是构建两类有价值的杂芳烃的高度竞争性方法，它们具有进一步阐明的有用位置。电子结构计算表明，事件的顺序涉及sp 3处硫属元素原子的攻击碳和烷基-氧裂解。清楚地表明了酸催化的关键作用，并证明了酸强度的重要性。计算的势垒也与所观察到的硫酰胺和酰胺反应性顺序完全一致。自发的开环涉及适度的CO裂解，减缓了应力释放的程度。在酸催化的途径上，CO的裂解仍然不太广泛，但是通过羧酸催化剂，质子转移到核反应堆中的进展非常快，而基本上是用甲磺酸完成的。
• TiCl3OTf-[bmim]Br: a novel and efficient catalyst system for chemoselective one-pot synthesis of thioamides from arylaldoximes
  作者：Jalil Noei、Ahmad R. Khosropour

  DOI：10.1016/j.tetlet.2008.09.084

  日期：2008.12

  The combination of TiCl3OTf with 1-butyl-3-methylimidazolium bromide is found to be an efficient and novel catalytic system for chemoselective one-pot transformation of arylaldoximes to their corresponding thioamides in high to excellent yields.

  发现TiCl 3 OTf与1-丁基-3-甲基咪唑鎓溴化物的组合是一种高效新颖的催化系统，用于以高产率至优异产率将芳基醛肟化学选择性地一锅转化为相应的硫代酰胺。
• Achiral Derivatives of Hydroxamate AR-42 Potently Inhibit Class I HDAC Enzymes and Cancer Cell Proliferation
  作者：Jiahui Tng、Junxian Lim、Kai-Chen Wu、Andrew J. Lucke、Weijun Xu、Robert C. Reid、David P. Fairlie

  DOI：10.1021/acs.jmedchem.0c00230

  日期：2020.6.11

  active inhibitor of histone deacetylases (HDACs) in clinical trials for multiple myeloma, leukemia, and lymphoma. It has few hydrogen bond donors and acceptors but is a chiral 2-arylbutyrate and potentially prone to racemization. We report achiral AR-42 analogues incorporating a cycloalkyl group linked via a quaternary carbon atom, with up to 40-fold increased potency against human class I HDACs (e

  在多发性骨髓瘤，白血病和淋巴瘤的临床试验中，AR-42是组蛋白脱乙酰基酶（HDAC）的口服活性抑制剂。它几乎没有氢键供体和受体，但是是手性的2-芳基丁酸酯，可能易于消旋。我们报道了非手性AR-42类似物，其包含通过季碳原子连接的环烷基，对人类I类HDAC的效力提高了40倍（例如，JT86，IC 500.7 nM，HDAC1），对五种人类癌细胞系的细胞毒性增加了25倍，而对正常人类细胞的毒性降低了多达70倍。JT86在促进MM96L黑色素瘤细胞中乙酰化组蛋白H4积累方面比racAR-42强9倍。分子模型和结构-活性之间的关系支持四氢吡喃与HDAC1的结合，而四氢吡喃则是对酶表面水的疏水屏蔽。这种有效的I类HDAC抑制剂可在AR-42活跃的疾病（癌症，寄生虫感染，炎性疾病）中显示出益处。
• PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF
  申请人：DENG Shaojiang

  公开号：US20080004309A1

  公开（公告）日：2008-01-03

  The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF).

  这项发明涉及一种能够调节缺氧诱导因子（HIF）稳定性和/或活性的新化合物。
• MEDICINAL COMPOSITIONS
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1402900A1

  公开（公告）日：2004-03-31

  The present invention relates to an agent for the prophylaxis or treatment of pain, an agent for suppressing activation of osteoclast, and an inhibitor of osteoclast formation, which contains a p38 MAP kinase inhibitor and/or a TNF-α production inhibitor.

  本发明涉及一种用于预防或治疗疼痛的药剂，一种用于抑制破骨细胞活化的药剂，以及一种包含p38 MAP激酶抑制剂和/或TNF-α产生抑制剂的破骨细胞形成抑制剂。